[1] Flores B, Trivedi H D, Robson S C, et al. Hemostasis, bleeding and thrombosis in liver disease [J]. J Transl Sci, 2017, 3(3).
[2] Islam R, Kundu S, Jha S B, et al. Cirrhosis and Coagulopathy: Mechanisms of Hemostasis Changes in Liver Failure and Their Management [J]. Cureus, 2022, 14(4): e23785.
[3] 朱萌然, 胡宵月, 苏芮, 等. 肝硬化凝血功能紊乱与出血、血栓形成的研究进展 [J]. 临床荟萃, 2024, 39(07): 658-663.
[4] Hugenholtz G C, Northup P G, Porte R J, Et Al. Is there a rationale for treatment of chronic liver disease with antithrombotic therapy? [J]. Blood Rev, 2015, 29(2): 127-136.
[5] Tripodi A, Mannucci P M. The coagulopathy of chronic liver disease [J]. N Engl J Med, 2011, 365(2): 147-156.
[6] tripodi a, anstee q m, sogaard k k, et al. Hypercoagulability in cirrhosis: causes and consequences [J]. J Thromb Haemost, 2011, 9(9): 1713-1723.
[7] Northup P G, Garcia-Pagan J C, Garcia-Tsao G, et al. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases [J]. Hepatology, 2021, 73(1): 366-413.
[8] O'Shea R S, Davitkov P, Ko C W, et al. AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis [J]. Gastroenterology, 2021, 161(5): 1615-1627.e1.
[9] Patel I J, Rahim S, Davidson J C, et al. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part II: Recommendations: Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe [J]. J Vasc Interv Radiol, 2019, 30(8): 1168-1184.e1.
[10] Roberts L N, Lisman T, Stanworth S, et al. Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH [J]. J Thromb Haemost, 2022, 20(1): 39-47.
[11] Tapper E B, Warner M A, Shah R P, et al. Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty Delphi [J]. Hepatology, 2024, 80(2): 488-499.
[12] O'Leary J G, Greenberg C S, Patton H M, et al. AGA Clinical Practice Update: Coagulation in Cirrhosis [J]. Gastroenterology, 2019, 157(1): 34-43.e1.
[13] Shenoy A, Louissaint J, Shannon C, et al. Viscoelastic Testing Prior to Non-surgical Procedures Reduces Blood Product Use Without Increasing Bleeding Risk in Cirrhosis [J]. Dig Dis Sci, 2022, 67(11): 5290-5299.
[14] Pillai A A, Kriss M, Al-Adra D P, et al. Coagulopathy and hemostasis management in patients undergoing liver transplantation: Defining a dynamic spectrum across phases of care [J]. Liver Transpl, 2022, 28(10): 1651-1663. |
